ArticleJournal of medicinal chemistry2025

Discovery of Novel, Potent, and Orally Bioavailable SMARCA2 Proteolysis-Targeting Chimeras with Synergistic Antitumor Activity in Combination with Kirsten Rat Sarcoma Viral Oncogene Homologue G12C Inhibitors.

Sasikumar Kotagiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.